Concepedia
Statistics
Publications
7
Citations
228
H-Index
Active since
2019
Affiliations
Oregon Health & Science University(Current)
Harvard University
Inserm
Sage Bionetworks
Xiamen Tobacco Industry (China)
Daniel S. Derrick is an author at Oregon Health & Science University specializing in molecular biology, oncology, and prostate cancer.
Publications per year
2019–2024
Enzalutamide response in a panel of prostate cancer cell lines reveals a role for glucocorticoid receptor in enzalutamide resistant disease
Rebecca Smith, Moqing Liu, Tiera Liby et al. · Scientific Reports · 2020 · 76 citations · Full text
Medicine, Molecular Biology, Oncology +17
A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses
Sean M. Gross, Mark Dane, Rebecca Smith et al. · Communications Biology · 2022 · 37 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +16
Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer
Daniel J. Coleman, Lina Gao, Jacob Schwartzman et al. · Scientific Reports · 2019 · 36 citations · Full text
Community assessment of methods to deconvolve cellular composition from bulk gene expression
Brian S. White, Aurélien de Reyniès, Aaron M. Newman et al. · Nature Communications · 2024 · 28 citations · Full text
Life Sciences, Immunology, Oncology +17
BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer
Daniel J. Coleman, Lina Gao, Carly J. King et al. · Oncogene · 2019 · 27 citations · Full text
Life Sciences, Molecular Biology, Oncology +15
1–5 of 7